COMPANY PROFILE

Xeos

Explore full profile

Intraoperative PET-CT specimen imaging for surgical oncology

Ghent, BelgiumFounded 2019Health Tech & Medtech

Valuation $50–100M Last recorded · 2026

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Xeos

Xeos is a MedTech start-up company that is focused on improving outcomes in Surgical Oncology through innovations in molecular intra-operative imaging.

Our ultimate goal is to eliminate the risk for re-surgery through smarter specimen imaging.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2019
Headquarters: Ghent, Belgium
Employees: 31
Open positions: None listed
Dealroom signal: 0.0/100
Industry: Health
Sub-industry: Medical Devices
Sector: Health Tech & Medtech, Oncology, Surgery, Surgical Equipment
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

1 recorded event

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
EARLY VC✓Equity / VC	Jan 2026	$15M	$62M	Undisclosed	↗

Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Xeos website traffic

Latest recorded traffic for Xeos is 3.3K monthly website visits, up 13.8% over the last three months. Xeos's team declined 11.4% over the past year.

Latest monthly visits3.3K 3-month web change+13.8% 1-year team growth-11.4%

Monthly website visitsDec 2022–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
CBChangfeng BiologyInnovative medical devices for minimally invasive surgery	Ningbo, China	Operational	—	$4.1M	$14M
QSQuantitative SurgicalAdvanced robotic platform for minimally invasive cancer therapy	Mannheim, Germany	Operational
FLFocal Medical Technology LTD.Robotic platform for focal prostate cancer treatment, using image-guided electroporation to achieve high precision with minimal side effects	Isle, France	Operational
CSCurrent SurgicalInnovative surgical automation platform enhancing cancer treatment precision and efficiency	Washington DC, United States	Operational
RAResitu Medical ABOffers a revolutionary approach to tumour biopsies by combining biopsy with tumour removal, without surgical intervention, saving precious healthcare time and cost	Stockholms kommun, Sweden	Operational
QSQuantum SurgicalDemocratizes minimally invasive cancer treatment through preplanning, advanced robotic assistance, and tumor ablation confirmation	Montpellier, France	Operational
SUSurGuideDeveloping a medical device for rapid intra-operative inspection of surgical margins	Rotterdam, Netherlands	Operational
MMMonteris MedicalA medical device venture developing new technologies for the treatment of cancer	Plymouth, United States	Operational